- Home
- BXP vs TECH Comparison
BXP vs TECH Comparison
Compare BXP & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BXP
- TECH
- Stock Information
- Founded
- BXP 1970
- TECH 1976
- Country
- BXP United States
- TECH United States
- Employees
- BXP N/A
- TECH N/A
- Industry
- BXP Real Estate Investment Trusts
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BXP Real Estate
- TECH Health Care
- Exchange
- BXP Nasdaq
- TECH Nasdaq
- Market Cap
- BXP 11.4B
- TECH 9.9B
- IPO Year
- BXP 1997
- TECH 1989
- Fundamental
- Price
- BXP $70.43
- TECH $60.96
- Analyst Decision
- BXP Buy
- TECH Buy
- Analyst Count
- BXP 17
- TECH 13
- Target Price
- BXP $77.71
- TECH $70.58
- AVG Volume (30 Days)
- BXP 1.8M
- TECH 2.2M
- Earning Date
- BXP 10-28-2025
- TECH 11-05-2025
- Dividend Yield
- BXP 3.98%
- TECH 0.52%
- EPS Growth
- BXP N/A
- TECH N/A
- EPS
- BXP N/A
- TECH 0.46
- Revenue
- BXP $3,275,851,000.00
- TECH $1,219,635,000.00
- Revenue This Year
- BXP $2.59
- TECH $3.72
- Revenue Next Year
- BXP $2.31
- TECH $7.67
- P/E Ratio
- BXP N/A
- TECH $134.83
- Revenue Growth
- BXP N/A
- TECH 5.23
- 52 Week Low
- BXP $54.22
- TECH $46.01
- 52 Week High
- BXP $88.10
- TECH $80.80
- Technical
- Relative Strength Index (RSI)
- BXP 39.88
- TECH 53.73
- Support Level
- BXP $70.53
- TECH $61.37
- Resistance Level
- BXP $74.77
- TECH $66.96
- Average True Range (ATR)
- BXP 1.59
- TECH 1.83
- MACD
- BXP -0.14
- TECH -0.24
- Stochastic Oscillator
- BXP 9.06
- TECH 40.41
About BXP Boston Properties Inc.
BXP Inc. owns over 180 properties consisting of approximately 53 million rentable square feet of space. The portfolio is dominated by office buildings and is spread across major cities such as New York, Boston, San Francisco, Los Angeles, Seattle, and the Washington, D.C., region. The real estate investment trust also owns limited retail, hotel, and residential properties.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.